End-stage renal disease associated with metabolic syndrome: a study of biomarkers relevant to cardiovascular risk

被引：0
|
作者：
Bansal, V [1 ]
Saluk, J. [2 ]
Hoppensteadt, D. [2 ]
Syed, D. [2 ]
Abro, S. [2 ]
Guler, N. [2 ]
Wahi, R. [2 ]
Fareed, J. [2 ]
机构：
[1] Loyola Univ, Med Ctr, Nephrol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Pathol, Maywood, IL 60153 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO332-WED
引用
收藏
页码：873 / 873
页数：1
相关论文
共 50 条
  • [31] Down syndrome with end-stage renal disease
    Kute V.B.
    Vanikar A.V.
    Shah P.R.
    Gumber M.R.
    Patel H.V.
    Engineer D.P.
    Thakkar U.G.
    Trivedi H.L.
    Indian Journal of Clinical Biochemistry, 2013, 28 (4) : 429 - 432
  • [32] End-stage Renal Disease in Griscelli Syndrome
    Mahajan, Vidushi
    Sood, Shivanjali
    Das, Reena
    INDIAN JOURNAL OF NEPHROLOGY, 2022, 32 (05) : 521 - 521
  • [33] The "General Cardiovascular Disease Risk Score" underestimates the risk of cardiovascular events in patients with end-stage renal disease
    Gowdak, L. H. W.
    De Paula, F. J.
    Cesar, L. A. M.
    De Lima, J. J. G.
    EUROPEAN HEART JOURNAL, 2011, 32 : 94 - 94
  • [34] Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    Benedetto, FA
    Parlongo, S
    Cutrupi, S
    Iellamo, D
    Bonanno, G
    Rapisarda, F
    Fatuzzo, F
    Seminara, G
    Catalotti, A
    Malatino, LS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (10): : 2611 - 2617
  • [35] Prevalence of metabolic syndrome in patients with end stage renal disease and relevance of biomarkers
    Saluk, Jennifer
    Bansal, Vinod
    Hoppensteadt, Debra
    Syed, Daneyal
    Abro, Schuarazad
    Fareed, Jawed
    INTERNATIONAL ANGIOLOGY, 2016, 35 (01) : 47 - 56
  • [36] Prevalence of Metabolic Syndrome in Patients with End Stage Renal Disease and Relevance of Biomarkers
    Saluk, Jennifer
    Bansal, Vinod
    Hoppensteadt, Debra
    Syed, Daneyal
    Abro, Schuharazad
    Fareed, Jawed
    FASEB JOURNAL, 2015, 29
  • [37] Risk factors and mortality associated with calciphylaxis in end-stage renal disease
    Mazhar, AR
    Johnson, RJ
    Gillen, D
    Stivelman, JC
    Ryan, MJ
    Davis, CL
    Stehman-Breen, CO
    KIDNEY INTERNATIONAL, 2001, 60 (01) : 324 - 332
  • [38] Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease
    Sharma, Sumeet
    Farrington, Ken
    Kozarski, Robert
    Christopoulos, Christos
    Niespialowska-Steuden, Maria
    Moffat, Daniel
    Gorog, Diana A.
    EUROPEAN HEART JOURNAL, 2013, 34 (05) : 354 - +
  • [39] Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
    Blacher, J
    Guerin, AP
    Pannier, B
    Marchais, SJ
    London, GM
    HYPERTENSION, 2001, 38 (04) : 938 - 942
  • [40] Is preeclampsia a risk for end-stage renal disease?
    Ponticelli, Claudio
    Moroni, Gabriella
    KIDNEY INTERNATIONAL, 2019, 96 (03) : 547 - 549
12345